• AKVANO® expand_more
  • Pharma expand_more
  • Business scope expand_more
  • Company expand_more
    • About expand_more
    • Management expand_more
    • CEO – letter expand_more
  • Investors expand_more
    • Investors expand_more
    • Investerare expand_more
  • Media expand_more
logo
  • AKVANO® expand_more
  • Pharma expand_more
  • Business scope expand_more
  • Company expand_more
    • About expand_more
    • Management expand_more
    • CEO – letter expand_more
  • Investors expand_more
    • Investors expand_more
    • Investerare expand_more
  • Media expand_more
Home / IR contact / Corporate governance / Board of directors
  • IR contact
  • Press releases
  • Financial reports
  • Financial calendar
  • Corporate governance
    • Annual General Meeting
    • Board of directors
    • Management
    • Certified Adviser
  • The share
    • Shareholders
    • Incentive program
  • IPO and prospectus
    • TO1
  • Presentations
  • Subscribe
Investor menu
  • IR contact
  • Press releases
  • Financial reports
  • Financial calendar
  • Corporate governance
    • Annual General Meeting
    • Board of directors
    • Management
    • Certified Adviser
  • The share
    • Shareholders
    • Incentive program
  • IPO and prospectus
    • TO1
  • Presentations
  • Subscribe

Board of directors

logo

Technology

The AKVANO® platform

Pharma applications

Investors

Investor relations

Pressreleases

Business scope

Company

About

Management

Press

Contact

Contact page

info@lipidor.se

 

The information on this website is of general information nature and is not intended to replace personal medical advice from doctors and other healthcare professionals. Lipidor’s pharma products are investigational drugs and are not approved for commercial use.

Privacy policy

©2023 Lipidor AB. All rights reserved.